{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:33:24Z","timestamp":1790624004619,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010066","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T00:00:00Z","timestamp":1443139200000}}],"reference-count":42,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010066.pub2","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T15:35:15Z","timestamp":1443195315000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Calcium channel blockers for pulmonary arterial hypertension"],"prefix":"10.1002","volume":"2015","author":[{"given":"Zhiyu","family":"Fan","sequence":"first","affiliation":[{"name":"Singapore General Hospital; Department of Family Medicine Continuing Care; Outram Road, Singapore Singapore Singapore 169608"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjing","family":"Chen","sequence":"additional","affiliation":[{"name":"Singapore General Hospital; Department of Anesthesiology; Singapore General Hospital, Outram Road Singapore Singapore 169608"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmin","family":"Liu","sequence":"additional","affiliation":[{"name":"West China Institute of Women\u2019s and Children\u2019s Health, West China Second University Hospital, Sichuan University; Pulmonary Vascular Remodeling Research Unit, Department of Pediatrics; No.20, 3rd Section, Renmin South Road Chengdu Sichuan Province China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"key":"10.1002\/14651858.CD010066.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/01.hjh.0000379873.13405.81","article-title":"Telmisartan improves endothelial function in scleroderma patients with pulmonary hypertension","volume":"28","author":"Yatsyshyn","year":"2010","journal-title":"Journal of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD010066.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/10837450.2012.659258","article-title":"Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis : development, optimization and in vitro\/in vivo studies","volume":"18","author":"Basalious","year":"2013","journal-title":"Pharmaceutical Development and Technology"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0003|cit3","first-page":"187","article-title":"Diltiazem-induced changes in plasma beta-thromboglobulin and platelet aggregation in chronic cor pulmonale","volume":"118","author":"Camerone","year":"1986","journal-title":"La Clinica Terapeutica"},{"issue":"1","key":"10.1002\/14651858.CD010066.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1164\/arrd.1983.128.1.30","article-title":"Independence of oxygen consumption and systemic oxygen transport in patients with either stable pulmonary hypertension or refractory left ventricular failure","volume":"128","author":"Chappell","year":"1983","journal-title":"American Review of Respiratory Disease"},{"issue":"3","key":"10.1002\/14651858.CD010066.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0002-9149(82)80015-5","article-title":"Hemodynamic and gas exchange effects of intravenous diltiazem in patients with pulmonary hypertension","volume":"49","author":"Crevy","year":"1982","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD010066.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hrtlng.2004.06.010","article-title":"Living with pulmonary artery hypertension: patients' experiences","volume":"34","author":"Flattery","year":"2005","journal-title":"Heart Lung"},{"issue":"10","key":"10.1002\/14651858.CD010066.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1253\/circj.CJ-13-0443","article-title":"Double-blind, placebo-controlled clinical trial with a rho-kinase inhibitor in pulmonary arterial hypertension; a pilot efficacy trial","volume":"77","author":"Fukumoto","year":"2013","journal-title":"Circulation Journal"},{"issue":"4","key":"10.1002\/14651858.CD010066.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ahj.2004.10.012","article-title":"The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use","volume":"150","author":"Krasuski","year":"2005","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD010066.pub2-BIB0009|cit9","first-page":"198","article-title":"Comparative evaluation of acute effects of sublingual nifedipine and oral diltiazem by echocardiographic right ventricular systolic time intervals in primary pulmonary hypertension","volume":"38","author":"Mishra","year":"1986","journal-title":"Indian Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD010066.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD010066.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/hrt.59.6.696","article-title":"Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine","volume":"59","author":"Rozkovec","year":"1988","journal-title":"British Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD010066.pub2-BIB0012|cit12","first-page":"78","article-title":"Acute effect of sublingual nifedipine on right ventricular systolic time intervals in primary pulmonary hypertension - an echocardiographic study","volume":"37","author":"Wasir","year":"1985","journal-title":"Indian Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD010066.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF00054206","article-title":"Hemodynamic effects of nifedipine and oxygen in children with pulmonary hypertension","volume":"2","author":"Wimmer","year":"1988","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD010066.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"12 Suppl S","key":"10.1002\/14651858.CD010066.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"40S","DOI":"10.1016\/j.jacc.2004.02.032","article-title":"Diagnosis and differential assessment of pulmonary arterial hypertension","volume":"43","author":"Barst","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD010066.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0017|cit17","volume-title":"Basic and Clinical Pharmacology","author":"Bertram","year":"2007"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0018|cit18","unstructured":"Deeks JJ Higgins JPT Altman DG (editors) Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0019|cit19","volume-title":"National Guidelines for Clinical Application of Essential Medicines","author":"Editorial board of national guidelines for clinical application of essential medicines","year":"2009"},{"issue":"9","key":"10.1002\/14651858.CD010066.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"Journal of Clinical Hypertension"},{"issue":"5","key":"10.1002\/14651858.CD010066.pub2-BIB0021|cit21","first-page":"583","article-title":"Current Diagnostic and Prognostic Assessment of Pulmonary Hypertension","volume":"63","author":"Escribano Subias","year":"2010","journal-title":"Revista Espanola de Cardiologia"},{"issue":"5","key":"10.1002\/14651858.CD010066.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine. Dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"issue":"24","key":"10.1002\/14651858.CD010066.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension","volume":"25","author":"Gali\u00e8","year":"2004","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0025|cit25","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0026|cit26","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"9","key":"10.1002\/14651858.CD010066.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0028|cit28","volume-title":"Goodman & Gilman's The Pharmacological Basis of Therapeutics","author":"Laurence","year":"2006"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0029|cit29","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD010066.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","article-title":"Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McLaughlin","year":"2004","journal-title":"Chest"},{"issue":"13","key":"10.1002\/14651858.CD010066.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD010066.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.RES.38.2.99","article-title":"Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonists in isolated rat lungs","volume":"38","author":"McMurtry","year":"1976","journal-title":"Circulation Research"},{"issue":"1","key":"10.1002\/14651858.CD010066.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1183\/09031936.00092306","article-title":"An epidemiological study of pulmonary arterial hypertension","volume":"30","author":"Peacock","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"12 Suppl S","key":"10.1002\/14651858.CD010066.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathy in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0035|cit35","volume-title":"Pharmacology","author":"Rang","year":"2003"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0036|cit36","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"1","key":"10.1002\/14651858.CD010066.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.76.1.135","article-title":"High-dose calcium channel-blocking therapy for primary pulmonary hypertension. Evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy","volume":"76","author":"Rich","year":"1987","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD010066.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1378\/chest.104.1.236","article-title":"Primary pulmonary hypertension","volume":"104","author":"Rubin","year":"1993","journal-title":"Chest"},{"issue":"11","key":"10.1002\/14651858.CD010066.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/thorax.56.11.888","article-title":"New insights into the pathogenesis and treatment of primary pulmonary hypertension","volume":"56","author":"Rudarakanchana","year":"2001","journal-title":"Thorax"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD010066.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"25 Suppl D","key":"10.1002\/14651858.CD010066.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated Clinical classification of pulmonary hypertension","volume":"62","author":"Simonneau","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD010066.pub2-BIB0042|cit42","unstructured":"Sterne JAC Egger M Moher D (editors) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010066.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T18:59:30Z","timestamp":1661885970000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010066.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,25]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010066.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,25]]}}}